VM
LPCN icon

VHCP Management’s Lipocine LPCN Stock Holding History

VHCP Management’s Portfolio LPCN Stock Details LPCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$3.13M Hold
49,995
– – 3.36% 8
2016
Q3 		$3.79M Hold
49,995
– – 3.73% 7
2016
Q2 		$2.58M Hold
49,995
– – 2.68% 9
2016
Q1 		$8.63M Hold
49,995
– – 7.49% 4
2015
Q4 		$11M Sell
49,995
-24,706
-33% -$5.18M 6.64% 6
2015
Q3 		$15M Hold
74,701
– – 3.85% 8
2015
Q2 		$10.9M Buy
74,701
+35,294
+90% +$4.38M 3.07% 10
2015
Q1 		$4.62M Hold
39,407
– – 1.06% 17
2014
Q4 		$3.52M Hold
39,407
– – 0.97% 18
2014
Q3 		$4.09M Buy
39,407
+31,048
+371% +$3.86M 1.84% 12
2014
Q2 		$867K Buy
+8,359
New +$1,000K 0.46% 17

Other funds holding LPCN

RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
VMI
VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VHCP Management's LPCN Position: Q4 2016 in Review

VHCP Management held its Lipocine (LPCN) position steady in Q4 2016 at 49,995 shares worth $3.13M. The position accounts for 3.36% of the portfolio, ranked #8.

VHCP Management first reported a position in LPCN in Q2 2014 and has held it in 11 quarters since. The position peaked at $15M in Q3 2015. 58 funds tracked by Wall St. Rank hold LPCN as of Q4 2016.

  • VHCP Management held 49,995 shares of Lipocine worth $3.13M as of Q4 2016.
  • VHCP Management left its Lipocine share count unchanged in Q4 2016.
  • Lipocine made up 3.36% of VHCP Management's portfolio in Q4 2016, its #8 holding.
  • VHCP Management first reported a position in Lipocine in Q2 2014 and has held it in 11 quarters since.
  • VHCP Management's Lipocine position peaked at $15M in Q3 2015.
  • 58 funds tracked by Wall St. Rank held Lipocine as of Q4 2016.

Based on VHCP Management's 13F filing for Q4 2016, filed 13 Feb 2017.